View: | Wound Dressings | Burn Dressings | Surgical Dressings | Silverlon Home Page

Back to Silverlon Home Page
Better technology.
Better outcomes.™
                          
Silverlon Silver Burn, Surgical, and Wound Care Products
Advanced Antimicrobial Wound Care,
Burn, and Surgical Products

Silverlon Home Page
To view the most recent Silverlon® Clinical and Product Studies, please Click Here

 

Caution!

 

Images in this section are graphic in nature 
 


 

 

 

 

 

 

Scroll Down To View Cases

 

 

 

 

 

 

 


Deep Forehead Laceration

 

Clinical History:

MH is an 18-year-old female who was involved in a motor vehicle accident on October 19, 1993.  There was momentary loss of consciousness as the patient's head impacted the front windshield resulting in deep lacerations to the forehead.   The evening of the accident the patient was taken to the operating room for repair of the facial laceration (Photograph #MH1). 

The lacerations were deep, extending down to the periosteum (outer membrane of the bone) of the skull.  All wounds were closed with 6-0 nylon following appropriate debridement and wound irrigation.  Silverlon® dressing therapy was initiated immediately postoperatively.  The patient spent the next five days in the hospital recovering from the femur fracture and learning to ambulate non-weight bearing. The Silverlon® dressing was subsequently changed daily and continued until October 23, 1993.  By the third post injury day the patient's head lacerations were painfree.  
 

Sutures were removed in the office October 25, 1993.  Eight months after the injury photograph #MH-9 was taken.  At this time, the patient was offered further surgical procedures to reduce the scar tissue that was present.  She refused, stating that she was pleased with the result.

Clinical Significance:

Lacerations on the face, of this depth, often require subsequent plastic surgical procedures to reduce scar tissue and improve cosmetic appearance.   With the application of Silverlon® dressing technology in the operating room after the wound

was sutured closed, the following benefits were noted:

  • No tattooing of the skin, as commonly seen with the application of silver sulfadiazine (Silvadene™) cream, was present;

  • Reduced edema of the traumatized soft tissues.  Note that in areas, such as the eyelid, that  did not experience direct contact with the Silverlon® dressing treatment, edema was present;

  • No post-operative wound infection;

  • Minimal soft tissue scar, reducing necessity for further plastic surgical procedures.

 

Full and Partial Thickness Burn

Clinical History:

SB is a two-year-old female who suffered partial and full thickness thermal burns to her right foot and leg and right hand on July 4, 1998.  According to the mother the child fell into a camp-fire while playing.  The child was seen within 20 minutes of the time of injury in extreme pain.  Silverlon® dressings were applied to all thermally injured areas.  Within 20 minutes the child was calm and quiet; not expressing pain.  The patient was placed on oral antibiotics.  She followed up on July 7, 1998 for her first dressing change.  The dressings were removed without discomfort or pain and photographs were taken.  The necrotic partial thickness skin was removed without sedation and new Silverlon® dressings were applied.  The child followed up on July 8th, July 10th, and July 13th, at which time the dressings were changed and the wounds examined.  After July 13th, they did all dressing changes on a daily basis.  The child was subsequently seen on July 23rd and August 17th.  Final photographs were taken on February 23rd, 1999.

Before

After

Clinical Significance:

Partial and full-thickness thermal burns are complex and debilitating injuries.  Silverlon® dressing therapy simplifies the daily dressing treatment protocol.  Pain appears to be reduced within an hour after the application of the dressing.  The observed benefits of the Silverlon® dressing are:

  • Reduced wound edema (swelling) during the first 48 hours after injury;

  • Dressing changes were done by the mother 9 days after the injury;

  • Reduced the necessity of additional wound debridement;

  • Reduced hospitalization time;

  • No requirement for skin grafting.


Infected Foot with Soft Tissue Loss

Clinical History:

JR is a 54-year-old male who was involved in an accident with a lawnmower on September 1, 1992.  He was seen the day of the accident at a local hospital in Asheville, North Carolina, where he was taken to the operating room for wound debridement (removing dead and infected tissue) and stabilization of the open fractures of the 3rd , 4th , and 5th  metatarsals and cuboid bone of the foot.  The patient was placed on IV antibiotics post-operatively and admitted to the hospital.   On the 4th , 5th , 6th  and 24th  of September, while in the hospital, the patient was taken back to the operating room for further debridement of the wound.  Due to the amount of soft tissue loss and bone injury, the patient was subsequently scheduled for a vascularized composite graft (a graft with skin, muscle, and arterial and venous blood supply). He was given a fifty percent chance of success, with the possibility of amputation of the foot if the surgery failed.

The patient was very hesitant to go ahead with further surgery and contacted Dr. Flick's office, requesting a second opinion.  He was initially seen October 2, 1992 in Demorest, Georgia. (Photograph #JR-1).  Silverlon® dressing therapy was initiated without further wound debridement.  The patient was placed on oral antibiotics for 4 weeks.  On his return to the office October 19, 1992, surgical debridement of the wound was performed: removing a portion of avascular (without blood supply) bone and two pins that were projecting into the open wound. The patient returned to the office November 9, 1992 The gross infection and soft tissue swelling was resolving and the wound was closing.  No further wound debridement was undertaken. 

Over the next 4 months the wound healed with the exception of a small portion that was directly over an area of suspected osteomyelitis (bone infection).  March 31, 1993 reveals a small portion of the wound still open.   The slowness in wound healing was felt to be the result of possible underlying osteomyelitis.  Additional bone was removed from the bottom of the lesion, under local anesthetic in the office.  Silverlon® dressing therapy was continued by the patient.  Within 2 months, the wound was closed and skin healed (Photogaph #JR-5).  The patient has continued to do well and has regained an excellent range of motion of the foot, with a normal gait (walking) pattern

Clinical Significance:

Despite multiple surgical debridements, hospitalization, and appropriate antibiotics and wound care, the patient’s wound progressively enlarged and deepened.  Once Silverlon® dressing therapy was initiated, the wound started to reduce in size and heal. Silver ions supplied by the Silverlon® dressing dressings resulted in:

  • Reduction in wound edema (swelling);

  • Skin with normal sensation to light touch;

  • Minimal scar contracture and interference with mechanical foot function;

This case clearly demonstrates the necessity for proper wound debridement.  If avascular bone is present in the wound, Silverlon® dressing treatment will be ineffective until that portion of the bone that is avascular is surgically removed.  In this case, once the dead bone was removed the wound healed.  Silverlon® dressing treatment will not suffice for poor surgical technique, but will enhance wound healing once proper surgical standards are maintained.

All dressing changes were performed by the patient without physical therapy or nursing assistance.  A difficult wound infection with soft tissue loss problems turned into a simple daily dressing change performed by the patient.  With the rapid reduction in pain, the patient was able to mobilize the foot sooner and return to normal activities of daily living faster.


Silverlon Products Distributors For a printer friendly version of this Silverlon®
Clinical Information Page, please click here
Silverlon Products Distributors

Back to the Silverlon® Home Page

Contact Information

(Toll Free) Phone:
1-888-551-0188

    
E-Mail Us at:
info@silverlon.com

     FAX #:
501-679-3378

Argentum Medical, LLC.
240 81st Street
Willowbrook, Illinois 60527


All of the Silverlon® Wound Care, Burn Care, and Surgical Care Products
listed on this website are FDA Cleared.


Copyright © 1998-2007 Argentum Medical, LLC
All Rights Reserved.